View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Gerresheimer Group
31 March 2022

Gerresheimer Awarded Platinum Status by Chiesi

Pharma and medical technology specialist Gerresheimer has been awarded platinum status by its customer Chiesi. Classification as an especially high-quality supplier is based on a rating process carefully examining sustainability, economy, quality, innovation and service level.

Gerresheimer secured a top position in its customer Chiesi’s evaluation of the supply chain. Of the participating suppliers, only 9% exceeded the minimum score required for platinum status. In the individual rating in the categories of sustainability, economy, quality, innovation and service level, Gerresheimer performed above average, often achieving the highest evaluation of all participants, as was the case with product quality (100/100) and service level (88/100), for example.

Chiesi placed a special focus on sustainability. The goal is not only to generate more added value for shareholders, but to balance the benefits for humanity, the planet and financial targets. In the Chiesi Code of Interdependence, the Group pledges to only work with partners in its value chain that share its commitment to sustainability, meet the same high standards in terms of environmental compatibility, social performance and transparency, and do fair, responsible business.

In the category of sustainability in particular, Gerresheimer scored with its ratings for its business ethics (100/100) and its management system (93/100). As a platinum partner, Gerresheimer now plays a key role in developing a sustainable value chain together. Among other things, Chiesi has set itself the goal of carbon neutrality by 2035.

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being....
Gerresheimer is one of the leading specialists for the production of high-quality glass and plastic products for the international pharmaceutical and healthcare industry.
During the Covid-19 pandemic, Gerresheimer is focusing on aspects including business continuity, customer demand, and supply chain. In 2019, we paved the way for profitable...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology